Hazer tops Techboard rank

08/08/2016 - 15:05

Bookmark

Upgrade your subscription to use this feature.

Half of the top twelve trending companies in Techboard’s ranking this fortnight are health-techs, with Perth continuing to assert its credentials in the space.

Half of the top twelve trending companies in Techboard’s ranking this fortnight are health-techs, with Perth continuing to assert its credentials in the space.

Alcidion, Admedus, ResApp Health, Actinogen and Cynata Therapeutics all feature in the top dozen.

Listed clean-tech Hazer Group is the highest trending company of the fortnight, up four spots from last fortnight. 

The University of Western Australia spin-out demonstrated growth in almost all metrics, with employee growth, social media traction (in particular LinkedIn and Techboard), international press coverage, ASX share price and website rank.

In addition Hazer picked up one nomination from Techboard’s Panel of Experts.

The startup is commercialising an innovative process for producing hydrogen and graphite.

“We are delighted that Hazer has reached the number one spot on Techboard as we continue with the development and commercialisation of the Hazer process,” the company said.

“We are confident that the Hazer process will have significant impact on the future of both the hydrogen and graphite markets globally, and Techboard has been a fantastic platform to share our story with the Australian technology scene.”

Second highest trending was social media company migme, as it works towards finalising an $8 million capital raising, and has appointed new executives and entered into a partnership with mobile platform MOX.

Third ranked Alcidion Corporation enters the top 20 for the first time, capping off an eventful fortnight with the announcement of a memorandum of understanding with Western Health to use Alcidion’s clinical decision support systems across its three facilities.

The deal is worth over $2 million.

Admedus, a health-tech involved in bio-manufacturing, medical devices and vaccines was fourth highest trending.

The Malaga-based company announced a $16 million capital raising to fund ramp up of manufacturing and new product development, capturing mindshare and an expert nomination as a result.

Fastbrick Robotics (fifth) returns to the top ten, with good press coverage and reaching the finals of the WA Innovator of the Year awards.

Internet share trading forum HotCopper (sixth) was the highest trending unlisted company, and has released a prospectus for a $12 million capital raising.

Other high ranking unlisted startups included Family Zone (10th), Cycliq (13th) and Stirfire Studios (14th).

MyStorage becomes Keepspace

Self storage solutions provider MyStorage has rebranded as Keepspace, because of an existing Victorian business carrying a similar name. The startup provides a logistical end to end service that valets users’ belongings to and from storage.

Instatruck’s an instant finalist

Instatruck has been named a finalist in the WA Innovator of the Year awards. The truck matching service has only recently launched, applying the Uber model to trucks. The startup is based at co-working hub Sync Labs in Leederville.

BuildingApprovals is Landgate’s first startup in residence

BuildingApprovals.com has been accepted as the first startup in residence at SPUR @ Landgate. The startup provides a building permit automation solution.

Avita’s ReCell technology to be tested by US hospital

A US firefighters’ burns laboratory is carrying out clinical trials to test Avita Medical’s spray-on skin. As part of a research study, the Firefighters' Burn and Surgical Laboratory at MedStar Washington Hospital Center is helping to test the effectiveness of ReCell.

The device enables clinicians to harvest skin cells from small sections of a patient's own healthy donor skin, yielding a potential treatment for skin regeneration in a burn injury area.

In addition to the clinical trials, Avita Medical and MedStar have agreed that MedStar will further research its product using laboratory assays and testing.

"We've taken on a series of preclinical studies for Avita that are aimed at focusing on various aspects of this device, including testing the enzymatic, or skin digesting, components in differing conditions and also looking at next-generation augmentation of their technology," says Lauren Moffatt, PhD, director of the Burn Research Laboratory.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options